SCHEMBL3845503

SCHEMBL3845503

O=C(Nc1nccs1)C1CCN(c2ccnc3ccc(-c4cn(C(c5ccccc5)(c5ccccc5)c5ccccc5)nc4C(F)(F)F)cc23)CC1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 1/20 0.40
HPGD P15428 1/20 0.40
MEN1 O00255 3/20 0.39
KMT2A Q03164 3/20 0.39
HSD17B10 Q99714 2/20 0.39
GAA P10253 2/20 0.38
EGFR P00533 2/20 0.37
LMNA P02545 3/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
PKM P14618 1/20 0.37
KDM4E B2RXH2 1/20 0.36
USP2 O75604 1/20 0.36
TSHR P16473 1/20 0.36
HTT P42858 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
TRPV1 Q8NER1 1/20 0.35
RXFP1 Q9HBX9 1/20 0.35
PIK3CA P42336 1/20 0.35
MTOR P42345 1/20 0.35
POLB P06746 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3848141 0.87 CYP3A4 (0.50) CYP3A4HPGDHSD17B10GAAKDM4E
SCHEMBL3855550 0.85 CYP3A4 (0.37) CYP3A4HPGDHSD17B10PIK3CAMTOR
Hydrochloric Acid SCHEMBL3850477 0.81 MEN1 (0.42) CYP3A4HPGDMEN1KMT2AHSD17B10
SCHEMBL5854355 0.80 CYP3A4 (0.39) CYP3A4HPGDKMT2ALMNAPKM
SCHEMBL3846231 0.80 MAPKAPK2 (0.46) CYP3A4HPGDMEN1KMT2AHSD17B10
SCHEMBL3848728 0.80 CHRM4 (0.39) CYP3A4HPGDMEN1KMT2AUSP2
SCHEMBL5851864 0.79 CYP3A4 (0.38) CYP3A4HPGDMEN1KMT2AHSD17B10
SCHEMBL3846799 0.79 MTOR (0.40) CYP3A4HPGDKDM4ETRPV1MTOR
SCHEMBL3845276 0.79 CYP3A4 (0.37) CYP3A4HPGDMEN1KMT2ALMNA
SCHEMBL3850354 0.78 NCF1 (0.48) CYP3A4LMNAMTOR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2048142-A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof Eisai R&D Management Co., Ltd. (JP) 2009-04-15 EP disclosed
EP-1382603-B1 NITROGENOUS FUSED-RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF EISAI R&D MAN CO LTD (JP) 2008-07-23 EP disclosed
US-7074801-B1 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof EISAI CO., LTD. (JP) 2006-07-11 US disclosed
EP-1382603-A1 NITROGENOUS FUSED−RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF Eisai Co., Ltd. (JP) 2004-01-21 EP disclosed